prof. dr. J.A. (Jourik) Gietema
Professor
Telephone:
E-mail:
j.a.gietema umcg.nl
Research
Publications
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
Broekman, K. E., Hof, M. A. J., Touw, D. J., Gietema, J. A., Nijman, H. W., Lefrandt, J. D., Reyners, A. K. L. & Jalving, M., 2020, In : Investigational new drugs. 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls
Tromp, J., Boerman, L. M., Sama, I. E., Maass, S. W. M. C., Maduro, J. H., Hummel, Y. M., Berger, M. Y., de Bock, G. H., Gietema, J. A., Berendsen, A. J. & van der Meer, P., 20-Feb-2020, In : European Journal of Heart Failure. 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
Lobo, J., Gillis, A. J. M., van den Berg, A., Dorssers, L. C. J., Belge, G., Dieckmann, K-P., Roest, H. P., van der Laan, L. J. W., Gietema, J., Hamilton, R. J., Jeronimo, C., Henrique, R., Salvatori, D. & Looijenga, L. H. J., Dec-2019, In : Cells. 8, 12, 28 p., 1637.Research output: Contribution to journal › Article › Academic › peer-review
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial
Steenbruggen, T. G., Steggink, L. C., Seynaeve, C. M., van der Hoeven, J. J. M., Hooning, M. J., Jager, A., Konings, I. R., Kroep, J. R., Smit, W. M., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, A. D., Linn, S. C., Schaapveld, M., Jacobse, J. N., van Leeuwen, F. E., Schröder, C. P., van Tinteren, H., de Vries, E. G. E., Sonke, G. S. & Gietema, J. A., 30-Jan-2020, In : JAMA oncology. 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment
Rosas-Plaza, X., de Vries, G., Meersma, G. J., Suurmeijer, A. J. H., Gietema, J. A., van Vugt, M. A. T. M. & de Jong, S., Feb-2020, In : Molecular cancer therapeutics. 19, 2, p. 590-601 13 p.Research output: Contribution to journal › Article › Academic › peer-review
ID: 75154